KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Sales: 2011-2025

Historic Return on Sales for TherapeuticsMD (TXMD) over the last 13 years, with Sep 2025 value amounting to 0.08%.

  • TherapeuticsMD's Return on Sales fell 33.00% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 33.00%. This contributed to the annual value of 0.07% for FY2024, which is 206.00% up from last year.
  • As of Q3 2025, TherapeuticsMD's Return on Sales stood at 0.08%, which was up 146.58% from 0.03% recorded in Q2 2025.
  • Over the past 5 years, TherapeuticsMD's Return on Sales peaked at 6.57% during Q3 2022, and registered a low of -3.55% during Q4 2023.
  • In the last 3 years, TherapeuticsMD's Return on Sales had a median value of 0.07% in 2024 and averaged -0.39%.
  • Its Return on Sales has fluctuated over the past 5 years, first spiked by 845bps in 2022, then tumbled by 623bps in 2023.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Return on Sales stood at -0.91% in 2021, then skyrocketed by 250bps to 1.59% in 2022, then slumped by 513bps to -3.55% in 2023, then soared by 362bps to 0.07% in 2024, then plummeted by 33bps to 0.08% in 2025.
  • Its Return on Sales was 0.08% in Q3 2025, compared to 0.03% in Q2 2025 and 0.02% in Q1 2025.